Saturday, April 2, 2011: 1:00 PM-2:15 PM
Trinity Ballroom (Hilton Anatole)
Abstracts
150
The Paradox of Accuracy - C. difficile (CD) Polymerase Chain Reaction (PCR) Increases Nosocomial CD Rates While Decreasing CD-related Isolation Days
Jaime Belmares, MD, MPH, Loyola University Chicago Medical Center;
Herminia Pua, RN, BSN, Loyola University Chicago Medical Center;
Paul Schreckenberger, PhD, Loyola University Medical Center;
Jorge P. Parada, MD, MPH, Loyola University Medical Center
151
Challenges of Auditing Infection Prevention Practices in a Statewide CDI Collaborative
Lisa Hines, RN, CIC, The Ohio State University Medical Center;
Toni Tester, The Ohio State University Medical Center;
Yosef Khan, MBBS, MPH, The Ohio State University Medical Center;
Kurt Stevenson, MD, The Ohio State University Medical Center;
Carol Jacobson, RN, Ohio Hospital Association;
David Engler, PHD, Ohio Hospital Association;
Julie Mangino, MD, The Ohio State University Medical Center
152
Rates of Recurrence and Mortality Among Patients with a Diagnosis of Clostridium Difficile Infection in the United States: An Analysis Using National Health Insurance Claims and Survey Databases
Erik R. Dubberke, MD, MSPH, Washington University School of Medicine;
Stacey J. Ackerman, MSE, PhD, Covance Market Access Services Inc.;
Yaozhu J. Chen, MPA, Covance Market Access Services Inc.;
Rebecca Baik, BS, Covance Market Access Services Inc.;
Emmanuelle Hugentobler, MD, PhD, Optimer Pharmaceuticals, Inc.
154
New York State Department of Health: Mandatory Reporting of Clostridium difficile via National Healthcare Safety Network LabID Event – Survey to Determine Testing Methods and Policies
Kathleen A. Gase, New York State Department of Health;
KuangNan Xiong, New York State Department of Health;
Johanna B. Lee, New York State Department of Health;
Valerie Haley, New York State Department of Health;
Boldt Tserenpuntsag, New York State Department of Health;
Diana Doughty, New York State Department of Health;
Peggy Hazamy, New York State Department of Health;
Rachel L. Stricof, New York State Department of Health;
Marie Tsivitis, New York State Department of Health;
Victor Tucci, New York State Department of Health;
Carole Van Antwerpen, New York State Department of Health
155
New York State Department of Health: Mandatory Reporting of Clostridium difficile via National Healthcare Safety Network LabID Event – Audit Results
Kathleen A. Gase, New York State Department of Health;
KuangNan Xiong, New York State Department of Health;
Johanna B. Lee, New York State Department of Health;
Valerie Haley, New York State Department of Health;
Boldt Tserenpuntsag, New York State Department of Health;
Diana Doughty, New York State Department of Health;
Peggy Hazamy, New York State Department of Health;
Rachel L. Stricof, New York State Department of Health;
Marie Tsivitis, New York State Department of Health;
Victor Tucci, New York State Department of Health;
Carole Van Antwerpen, New York State Department of Health
157
Implementing Automated Surveillance to Track Clostridium difficile Infection (CDI) at Multiple Healthcare Facilities
Erik R. Dubberke, MD, MSPH, Washington University School of Medicine;
Humaa A. Nyazee, MPH, Washington University School of Medicine;
Deborah S. Yokoe, MD, MPH, Brigham and Women's Hospital and Harvard Medical School;
Jeanmarie Mayer, MD, University Hospital;
Victoria J. Fraser, MD, Washington University School of Medicine
160
Contact Isolation is No Longer Enough to Control C. difficile
Ryan Blanton, MS, MT, CIC, Wake Forest University Baptist Medical Center;
Sylvia Pegg, RN, BSN, CIC, Wake Forest University Baptist Medical Center;
Samantha Davies, BHA, MLT, Wake Forest University Baptist Medical Center;
Camp Jacquie, RN, BSN, CIC, Wake Forest University Baptist Medical Center;
Cindy Adkins, RN, CIC, Wake Forest University Baptist Medical Center;
Robert Sherertz, MD, Wake Forest University Baptist Medical Center
164
Electronic Surveillance for Clostridium difficile Infection (CDI)
Diane Hopkins-Broyles, RN, MSN, CIC, BJC Healthcare;
Joshua A. Doherty, BS, BJC Healthcare;
Angela Recktenwald, MPH, BJC Healthcare;
Kelly Faulkner, BJC Healthcare;
Erik R. Dubberke, MD, MSPH, Washington University School of Medicine;
Hilary Babcock, MD, Washington University School of Medicine;
Keith F. Woeltje, MD, PhD, BJC Healthcare
165
Evaluation of the Use of Groin Cultures for Detection of Asymptomatic Carriers of Clostridium difficile
Ajay K. Sethi, PhD, Louis Stokes Cleveland VA Medical Center;
Lucy A. Jury, NP, Louis Stokes Cleveland VA Medical Center;
Michelle M. Nerandzic, BS, Louis Stokes Cleveland VA Medical Center;
Sirisha Kundrapu, MD, Louis Stokes Cleveland VA Medical Center;
Curtis J. Donskey, MD, Louis Stokes Cleveland VA Medical Center
167
Impact of Clinical Symptoms on the Sensitivity and Specificity of Clostridium difficile Diagnostic Assays
Zhuolin Han, MD, Washington University School of Medicine;
Carey-Ann Burnham, PhD, Washington University School of Medicine;
Linda Bobo, Washington University School of Medicine;
Joan Hoppe-Bauer, Washington University School of Medicine;
Susan Copper, Washington University School of Medicine;
Brenda Lawrence, Washington University School of Medicine;
Wm. Michael Dunne, Washington University School of Medicine;
Erik R. Dubberke, Washington University School of Medicine
168
Relationship of CDC Surveillance Definitions and Mortality due to Clostridium difficile Infection (CDI) in Older Adults in South Eastern Michigan-A Multicenter Study
Teena Chopra, MD, Detroit Medical Center, Wayne State University;
Gagandeep Cheema, BS, Wayne State University;
Nena Auraha, BS, Wayne State University;
Jose F. Echaiz, MD, Henry Ford Hospital;
Laura Johnson, Henry Ford Hospital;
Richard Severson, PhD, Wayne State University;
Rama Thyagarajan, MD, Oakwood Health Care System;
Keith Mullins, BS, Wayne State University;
Dror Marchaim, MD, Detroit Medical Center, Wayne State University;
Suchitha Bheemreddy, MD, Detroit Medical Center, Wayne State University;
Ahmad Mohammadieh, Detroit Medical Center,Wayne State University;
Christopher Saddler, BS, Wayne State University;
Sorabh Dhar, MD, Detroit Medical Center, Wayne State University;
Keith .S Kaye, MD, MPH, Detroit Medical Center, Wayne State University;
George Alangaden, MD, Detroit Medical Center,Wayne State University
169
Do Proton Pump Inhibitors Predispose to Clostridium difficile Infection?
Kristina Aleksoniene, MD, Loyola University Medical Center;
Susan P. Sambol, BS, Hines VA Hospital;
Lorinda M. Wright, PhD, Hines VA Hospital;
Laurica A. Petrella, BS, Hines VA Hospital;
Dale N. Gerding, MD, Hines VA Hospital and Loyola University Medical Center;
Stuart Johnson, MD, Hines VA Hospital and Loyola University Medical Center
170
Molecular Epidemiology of Clostridium difficile Infection (CDI) in Children at a Tertiary Care Hospital - A Pilot Study
Anthony J. Perissinotti, PharmD, Wayne State University;
Teena Chopra, MD, Wayne State University;
Ahmed Mohammadieh, BS, Wayne State University;
Jing J. Zhao, PharmD, Wayne State University;
Paul Lephart, PhD, Wayne State University;
Lynn Semproch, BS, MT, MPH, Wayne State University;
Smitha Sathyaprakash, MD, Wayne State University;
Keith Kaye, MD, MPH, Wayne State University;
George Alangaden, MD, Wayne State University
171
Outcomes of Clostridium difficile Infection in Intra-abdominal solid organ transplant Recipients
Jacob Enser, School of Medicine and Public Health, University of Wisconsin;
Trevor McKown, School of Medicine and Public Health, University of Wisconsin;
Jennifer Hsu, University of Wisconsin Madison;
Valerie Knasinski, University of Wisconsin Madison;
John Pirsch, MD, School of Medicine and Public Health, University of Wisconsin;
Nasia Safdar, School of Medicine and Public Health, University of Wisconsin
173
Are outpatient Clinics and Emergency Departments A Potential Source For Acquisition of “Community-Associated” Clostridium difficile?
Lucy A. Jury, NP, Geriatric Research, Education, and Clinical Center, Louis Stokes Cleveland VA Medical Center;
Brett Sitzlar, Geriatric Research, Education, and Clinical Center, Louis Stokes Cleveland VA Medical Center;
Sirisha Kundrapu, MD, Louis Stokes Cleveland VA Medical Center;
Dubert Guerrero, Louis Stokes Cleveland VA Medical Center;
Kim M. Summers, BSN, Geriatric Research, Education, and Clinical Center, Louis Stokes Cleveland VA Medical Center;
Curtis J. Donskey, MD, Geriatric Research, Education, and Clinical Center, Louis Stokes Cleveland VA Medical Center
174
Recent Epidemiology and Outcome of Clostridium difficile Infection in Community Hospital
Pwint N. Htwe, MD, Maimonides Medical Center;
San S. Wong, MD, Maimonides Medical Center;
Khadija Chaudrey, MD, Long Island College Hospital;
Sadaf Mir, MD, Long Island College Hospital;
Takashi Shinha, MD, Long Island College Hospital;
Alma Magick, MD, Long Island College Hospital;
Kumar Pallav, MD, Long Island College Hospital;
Neda Motameni, MD, Long Island College Hospital;
Douglas Sepkowitz, MD, Long Island College Hospital;
Preeti Nautiyal, MD, Long Island College Hospital
177
Impact of North American Pulsed-field Type 1 (NAP1) Clostridium difficile Strain on Disease Severity and Outcome
Jessica Cohen, MPH, Centers for Disease Control and Prevention;
Duncan R. MacCannell, PhD, Centers for Disease Control and Prevention;
Stacy M. Holzbauer, DVM, CDC CEFO assigned to the MN Dept. of Hlth;
Kelly R. Kast, MSPH, Colorado Department of Health;
Ghinwa Dumyati, MD, University of Rochester;
Lisa Winston, MD, UCSF Department of Medicine;
Michelle Whitbread, CT Emerging Infections Program;
L. Clifford McDonald, MD, Centers for Disease Control and Prevention;
Fernanda C. Lessa, MD, MPH, Centers for Disease Control and Prevention
179
Predictors of Recurrent Clostridium difficile Infection (CDI) in Older Adults –A Multicenter Case-Control Study
Teena Chopra, MD, Detroit Medical Center, Wayne State University;
Christopher Saddler, BS, Wayne State University;
Suchitha Bheemreddy, MD, Detroit Medical Center, Wayne State University;
Smitha Sathyaprakash, MD, Detroit Medical Center, Wayne State University;
Jose F. Echaiz, MD, Henry Ford Hospital;
Laura Johnson, MD, Henry Ford Hospital;
Richard Severson, PhD, Wayne State University;
Rama Thyagarajan, MD, Oakwood Health Care System;
Keith Mullins, BS, Wayne State University;
Anthony J. Perissinotti, PharmD, Detroit Medical Center, Wayne State University;
Gagandeep Cheema, BS, Wayne State University;
Nena Auraha, BS, Wayne State University;
Dror Marchaim, MD, Detroit Medical Center, Wayne State University;
Sorabh Dhar, MD, Detroit Medical Center, Wayne State University;
Keith S. Kaye, MD, MPH, Detroit Medical Center, Wayne State University;
George Alangaden, MD, Detroit Medical Center, Wayne State University
180
A Simplified Method for Environmental Culturing for Clostridium difficile
Scott Curry, MD, Univ of Pittsburgh Med Ctr;
Travis M. Hamilton, BS, Univ of Pittsburgh Med Ctr;
Jane W. Marsh, PhD, Univ of Pittsburgh Med Ctr;
Carlene A. Muto, MD, MS, Univ of Pittsburgh Med Ctr;
A. William Pasculle, ScD, Univ of Pittsburgh Med Ctr;
Lee H. Harrison, MD, Univ of Pittsburgh Med Ctr
181
A Pilot Study of Persistence of Clostridium difficile Contamination After Terminal Disinfection with 10% Bleach
Scott Curry, MD, Univ of Pittsburgh Med Ctr;
Travis M. Hamilton, BS, Univ of Pittsburgh Med Ctr;
Nakita T. Brown, BS, Univ of Pittsburgh Med Ctr;
Jane Marsh, PhD, Univ of Pittsburgh Med Ctr;
Carlene Muto, MD, MS, Univ of Pittsburgh Med Ctr;
Lee H. Harrison, MD, Univ of Pittsburgh Med Ctr
182
A Point Prevalence Study of Hospital-based GI Clinic Environmental Contamination With Toxigenic Clostridium difficile
Scott Curry, MD, Univ of Pittsburgh Med Ctr;
Nakita T. Brown, BS, Univ of Pittsburgh Med Ctr;
Jane Marsh, PhD, Univ of Pittsburgh Med Ctr;
Carlene Muto, MD, MS, Univ of Pittsburgh Med Ctr;
Lee H. Harrison, MD, Univ of Pittsburgh Med Ctr;
David Binion, MD, Univ of Pittsburgh Med Ctr
183
The effect of PCR diagnosis on Clostridium difficile infection rates
Jose Cadena, MD, South Texas Veterans Health Care System and University of Texas Health Science Center;
Patti Grota, RN, PhD, South Texas Veterans Health Care System;
Christopher R. Frei, Pharm, D, The University of Texas at Austin and The University of Texas Health Science Center at San Antonio;
Jan E. Patterson, MD, South Texas Veterans Healthcare System, University of Texas Health Science Center at San Antonio
185
Effectiveness of Empiric Contact Isolation and Treatment for Clostridium difficile: A Simulation-Based Approach
Michael Rubin, MD, PhD, VA Salt Lake City IDEAS Center;
Makoto Jones, MD, University of Utah;
Angela Huttner, MD, University of Utah;
Jose Benuzillo, MS, IDEAS Center;
Damon Toth, PhD, University of Utah;
Karim Khader, University of Utah;
William R. Ray, VA Salt Lake City IDEAS Center;
Larry C. Ford, MD, University of Utah School of Medicine;
Theodore Sablay, IDEAS Center;
Dale Gerding, MD, Hines VA Hospital;
Matthew Samore, MD, VA Salt Lake City IDEAS Center
186
Preoperative Risk Factors for Clostridium difficile Infection in Colectomy Patients
Greta Krapohl, RN, MSN, PhD(c), University of Michigan School of Nursing;
Darrell Campbell, MD, University of Michigan Health System, Michigan Surgical Quality Collaborative;
Allison E. Aiello, PhD, MS, University of Michigan School of Public Health;
Bonnie L. Metzger, RN, PhD, FAAN, University of Michigan School of Nursing
187
Differences in Clinical Outcomes of C. difficile by Cytotoxicity Assay and NAP1 Status: Review of 125 Patients at a Cancer Hospital
Anna Kaltsas, MD, MS, Memorial Sloan Kettering Cancer Center;
Matt Simon, MD, New York Presbyterian Hospital - Weill Cornell;
Larissa Unruh, BS, Columbia University, Mailman School of Public Health;
Crystal Son, MPH, Memorial Sloan Kettering Cancer Center;
Danielle Wroblewski, PhD, Wadsworth Center, NYS Dept of Health;
Kimberlee A. Musser, PhD, Wadsworth Center, NYS Dept of Health;
Ngolela Esther Babady, PhD, Memorial Sloan Kettering Cancer Center;
Kent Sepkowitz, MD, Memorial Sloan Kettering Cancer Center;
Mini Kamboj, MD, Memorial Sloan Kettering Cancer Center
188
Multiple Interventions are Necessary to Decrease C Difficile Infections
Judith Strymish, MD, VA Boston HCS;
Stephen Brecher, PhD, VA Boston HCS;
Cindy Tibert, RN, VA Boston HCS;
Deborah Hylander, RN, VA Boston HCS;
Kalpana Gupta, MD, BU School of Medicine
190
The Clean Team: A Controlled Study to Measure the Effect of Enhanced Environmental Cleaning on Hospital-acquired C. difficile Illness
Michael Phillips, MD, New York University Langone Medical Center;
Hilda Pineda, BA, New York University Langone Medical Center;
Alex Rowan-hazelrigg, RN, New York University Langone Medical Center;
Yanina Dubrovskaya, PharmD, New York University Langone Medical Center;
Peter Aguilar, BA, New York University Langone Medical Center;
Jeffrey Short, MBA, New York University Langone Medical Center;
Amy Horrocks, MPA, New York University Langone Medical Center;
John Papadopoulos, PharmD, New York University Langone Medical Center;
Sapna Mehta, MD, New York University Langone Medical Center;
Robert Press, MD, PhD, New York University Langone Medical Center
191
Clostridium difficile Infection: What is the True Incidence?
Angela Huttner, MD, University of Utah;
Makoto Jones, MD, University of Utah;
Michael Rubin, MD, PhD, University of Utah;
Jeanmarie Mayer, MD, University of Utah School of Medicine;
Matthew Samore, MD, University of Utah
![[ Visit SHEA online ]](images/banner.gif)